Compare YCBD & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YCBD | AMS |
|---|---|---|
| Founded | 2015 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5M | 14.2M |
| IPO Year | N/A | N/A |
| Metric | YCBD | AMS |
|---|---|---|
| Price | $0.93 | $2.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 13.0M | 8.9K |
| Earning Date | 02-12-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $19,190,468.00 | ★ $29,423,000.00 |
| Revenue This Year | $6.94 | $3.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.84 |
| 52 Week Low | $0.47 | $2.01 |
| 52 Week High | $6.54 | $3.26 |
| Indicator | YCBD | AMS |
|---|---|---|
| Relative Strength Index (RSI) | 42.48 | 49.48 |
| Support Level | $1.03 | $2.12 |
| Resistance Level | $1.20 | $2.20 |
| Average True Range (ATR) | 0.16 | 0.05 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 2.51 | 50.00 |
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.